Seladelpar – December 2025

• Brand names:
  • Livdelzi®
• Pharmaceutical Company:
  • GILEAD SCIENCES PTY LTD
• Condition/Indication: Primary biliary cholangitis (PBC)
• Meeting Date: December 2025
• Public Summary Document (PSD) July 2025 – December 2025 PBAC Meeting – (PDF 1.2MB)
• Public Summary Document (PSD) July 2025 – December 2025 PBAC Meeting – (Word 437KB)

Related Public Summary Documents

• Seladelpar – July 2025